At Northern Leaf, we deliver pharmaceutical-grade and EU-GMP-compliant medical cannabis for large-scale export to international markets. 

Operating one of Europe’s largest EU-GMP-licensed medical cannabis manufacturing facilities in the Channel Island of Jersey, Northern Leaf is committed to delivering a high-quality, consistent and compliant supply our partners can rely on.  

Following a change in leadership in 2024, the company has undergone a major turnaround, increasing capacity at its 100,000 square ft facility from 25% to 75% in under two years.  

We are now entering our next growth stage and are focused on expansion into vertically integrated activities and on strengthening our portfolio with innovation and investment in pharmaceutical R&D, demonstrating our firm commitment to advancing the field of cannabis-based medicine.   

DISCLAIMER: We do not sell directly to patients or clinics.

Northern Leaf

Org chart

Teams

Offices